Exosens Revenue

In the year 2024, Exosens had annual revenue of 394.10M EUR with 35.05% growth. Exosens had revenue of 207.20M in the half year ending December 31, 2024.

Revenue

394.10M EUR

Revenue Growth

+35.05%

P/S Ratio

4.80

Revenue / Employee

231.82K EUR

Employees

1,700

Market Cap

1.56B GBP

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	394.10M	102.28M	35.05%
Dec 31, 2023	291.82M	91.07M	45.36%
Dec 31, 2022	200.75M	34.58M	20.81%
Dec 31, 2021	166.17M	16.31M	10.88%
Dec 31, 2020	149.86M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	42.56B
Shell	227.10B
HSBC Holdings	44.89B
Unilever	50.25B
Rio Tinto Group	42.86B
RELX PLC	9.43B
British American Tobacco p.l.c.	25.87B
Rolls-Royce Holdings	18.91B

Revenue Rankings

Exosens News

4 days ago - Exosens reaffirms 2024 outlook as NATO demand lifts sales - Seeking Alpha
24 days ago - Exosens: Spectral And Imaging Opportunity With Attractive End Markets - Seeking Alpha

More News